PYC Therapeutics advances eye disease drug trials update
PYC Therapeutics Advances Blinding Eye Disease Drug Trials: A New Dawn for Patients For the hundreds of thousands of individuals worldwide living with inherited retinal diseases (IRDs), the world can slowly fade to darkness. These genetic conditions, which include retinitis pigmentosa and Stargardt disease, have long been considered untreatable, leading to progressive vision loss and, […]
PYC Therapeutics advances eye disease drug trials update Read More »










